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Abstract Since glutathione (GSH) protects against oxidative
stress, we determined the regulation of cellular GSH by ionizing
radiation in human hepatoblastoma cells, HepG2. The levels of
GSH increased in irradiated HepG2 due to a greater Q-
glutamylcysteine synthetase (Q-GCS) activity, which was paral-
leled by Q-GCS heavy subunit chain (Q-GCS-HS) mRNA levels.
Transcription of deletion constructs of the Q-GCS-HS promoter
cloned in a reporter vector was associated with activator protein-
1 (AP-1), consistent with the DNA binding of AP-1 in nuclear
extracts of irradiated HepG2. Hence, the transcriptional
regulation of Q-GCS by ionizing radiation emerges as an
adaptive mechanism, which may be of significance to control
the consequences of the oxidative stress induced by radiation.
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1. Introduction
One of the best characterized biological e¡ects of ionizing
radiation is the overgeneration of ROS [1,2], which interacts
with cellular macromolecules and participates in the chain of
events that culminate in cell death. To control these potential
harmful e¡ects of ROS overproduction, irradiated cells may
trigger adaptive mechanisms, such as induction of cellular
antioxidants [3]. Indeed, previous studies have demonstrated
that overexpression of Mn-SOD a¡ords survival of tumor
cells to ionizing radiation, highlighting the relevant role of
antioxidants in the control of the oxidative stress induced
by radiation [3].
Glutathione (GSH), the main nonprotein cellular thiol,
plays a prominent role in the defense against oxidative
stress-induced cell injury [4^6]. To ful¢l such a role, reduced
GSH acts as substrate for the GSH S-transferase and GSH
peroxidase, downplaying the levels of ROS and of a wide
variety of toxic compounds including many chemotherapeutic
and alkylating drugs [7^9]. Conjugation of these agents with
GSH generally results in their inactivation and, in some cases,
facilitates their excretion from cells. Furthermore, due to its
protective role in maintaining critical cellular functions, cer-
tain cancer cells develop resistance against chemotherapeutic
agents by up-regulating the GSH levels [10,11].
GSH is synthesized from its constituent amino acids in two
sequential enzymatic reactions, catalyzed by Q-glutamylcys-
teine synthetase (Q-GCS) and GSH synthetase. Q-GCS cata-
lyzes the rate limiting step in de novo GSH synthesis, and is
inhibited by GSH through a feedback mechanism. Q-GCS has
been shown to be up-regulated in multiple cell types in re-
sponse to a wide variety of stimuli, including alkylating com-
pounds, chemotherapeutic agents and cigarette smoke [12^17].
In this regard, although previous studies have shown that
certain strains of E. coli endowed with a greater capacity to
synthesize GSH by gene transfer are resistant to radiation
[18], the regulation of Q-GCS in response to radiation has
not been reported to the best of our knowledge. Here, we
provide evidence that ionizing radiation increases cellular
GSH level by transcriptional regulation of the heavy chain
of Q-GCS, which may constitute an adaptive response to con-
trol the consequences of ROS and the oxidative stress induced
by radiation.
2. Materials and methods
GSH, GSSG, cysteine and BSO were obtained from Sigma Chem-
ical Co. (St. Louis, MO). Monochlorobimane and DCFDA were from
Molecular Probes (Eugene, OR). Trizol LS reagent and lipofectamine
were obtained from Life Technologies (Gaithersburg, MD). Q-Gluta-
mylcysteine was prepared by enzymatic hydrolysis of GSSG and re-
duction with dithiothreitol prior to use as described [19]. The human
hepatoblastoma cell line, HepG2, was purchased from ATTC and
routinely cultured in DMEM containing 10% FBS, penicillin and
streptomycin (0.1 mg/ml) in a humidi¢ed atmosphere of 5% CO2/
95% air, at 37‡C and were subcultured every 7 days, changing culture
medium every 3^4 days.
2.1. Irradiation of HepG2
Subcon£uent HepG2 cells were pelleted and washed once with PBS
and resuspended at 10U106 cells/ml. To ensure a homogeneous radi-
ation dose on all samples, cells were added to 1 cm polystyrene tubes
and ¢lled with PBS. Cells were irradiated in a linear accelerator (KDS
Siemens) at room temperature using an electron beam of 18 meV.
Doses between 50 and 500 cGy were applied at a rate of 300 cGy/
min. Estimated errors on dose were below 1%. Immediately after
radiation cells were cultured as indicated above. HepG2 cells were
maintained in culture for 15 days. Cells were counted automatically
with a Coulter Multisizer II and veri¢ed using a hemocytometer. Cell
viability was determined by trypan blue exclusion (0.2%) and propi-
dium iodide labeling.
2.2. Determination of total GSH equivalents and synthetic rate of GSH
Molecular forms of GSH equivalents, mainly reduced (GSH) and
oxidized form (GSSG), were determined by HPLC as described pre-
viously [20]. The dynamic rate of GSH synthesis was determined in
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cell-free extracts as described in detail previously [21]. Brie£y, cell
extracts were dialyzed overnight at 4‡C to deplete cytosol GSH con-
tent to minimize feedback inhibition of GSH on Q-GCS. The GSH
synthetic capacity was determined using GSH precursors, glutamate,
glycine, cysteine and monochlorobimane as described previously in
detail [21]. GSH synthetase activity was assayed using glycine and Q-
glutamylcysteine instead of cysteine and glutamate. The rate of GSH
formation was monitored as the net rate of £uorescence increase of
GSH-monochlorobimane adduct catalyzed by GST over time after
subtracting the BSO-inhibitable £uorescence signal [21].
2.3. Preparation of nuclear extracts and EMSA assay for NF-UB and
AP-1
Nuclear extracts were prepared as described previously [22]. Acti-
vation of AP-1 and NF-UB was determined by electrophoretic mobil-
ity shift assays (EMSA), using consensus probes for AP-1 (5P-
CGCTTGATGAGTCAGCCGGAA-3P) and UB (5P-AGTTGAGGG-
GACTTTCCCAGGC-3P), labeled at the 5P end with T4 kinase and
Q-32P-ATP (3000 Ci/mmol). Proteins (15 mg) were separated through
native 6% polyacrylamide gel and visualized by autoradiography.
2.4. Analysis of Q-GCS-HS mRNA
A cDNA probe for Q-GCS-HS was generated by RT-PCR. An 804-
base pair partial cDNA was prepare using rat kidney RNA [23],
cloned into pTARGET (Promega, Madison, WI) and sequenced using
fmol DNA sequencing system (Promega) to discard PCR-induced
mutations. Twenty mg of RNA was size fractionated in a 1% agarose
at 2 V/cm under denaturing conditions, and transferred on nylon
membrane and ¢xed with UV. The membranes were prehybridized
at 65‡C and hybridizations were performed using the 32P-labeled
Q-GCS-HS probe. mRNA levels were calculated relative to the 18S
band used as an internal reference control and expressed as percentage
of control. Densitometry quantitation of autoradiographs was per-
formed with a densitometer Preference (Seba, France).
2.5. Generation of Q-GCS-HS promoter and deletion constructs
The Q-GCS-HS promoter was ampli¢ed by PCR from genomic
DNA (150 ng) using the following upstream oligonucleotide 5P
(+225) GGAGGCGCAGGCAGAAGACCGA-3P and downstream
oligonucleotide 5P (31088) CAGCCAGACCTTGGGTATTCATG-
3P as described previously [11,12]. The resulting promoter fragment
(31088 to +225) was cloned into pTARGET. Using the restriction
enzymes KpnI and XhoI, two fragments of 277 and 1054 bp were
subsequently obtained. These fragments and the total promoter
(1336 bp) were subcloned into polylinker of the promoterless plasmid
pCAT 3 Enhancer vector (Promega). The 1054 bp fragment contained
AP-1, AP-2 and MRE regulatory sites, whereas the 277 bp fragment
encompassed the NF-UB and ARE sites.
2.6. Transient transfection and CAT assay
HepG2 cells were seeded in 6-well plates and cultured until 65^75%
cell con£uence. pCAT 3 Enhancer and pCAT 3 Control plasmids were
transfected using the lipofectamine reagent, according to the manu-
facturer’s instructions. Thirty-six h after transfection, cells were irra-
diated (400 cGy) as described above. Eight h post-radiation, cell ex-
tracts were isolated and protein determined (Bio-Rad, Hercules, CA).
Chloramphenicol acetyl transferase (CAT) activity was quantitated by
the CAT ELISA (Boehringer Mannheim, Mannheim, Germany). L-
Galactosidase expression plasmid (PSVgal, Promega) was cotrans-
fected as an internal control to normalize the transfection e⁄ciency.
2.7. Statistical analyses
Statistical analyses for multiple comparisons of mean values be-
tween cell preparations were made by one-way ANOVA followed
by Fisher’s test.
3. Results and discussion
The interaction of ionizing radiation with cells in the pres-
ence of molecular oxygen leads to generation of ROS, causing
oxidative stress. Indeed, an overproduction of ROS stands as
one of the major mechanisms involved in the killing of cells by
ionizing radiation [24,25]. Since cells may adapt to stress con-
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Fig. 1. Regulation of cell GSH and Q-GCS activity by ionizing radiation. A: Cells were radiated (400 cGy) and total cellular GSH equivalents
(GSH+GSSG) shown were determined by HPLC. Results were determined in duplicate plates and the mean þ S.D. of three di¡erent experi-
ments shown. *P6 0.05 vs. control. B: HepG2 cells were radiated at di¡erent doses (0^10 Gy) and GSH content was analyzed by HPLC after
4^5 h post-radiation. Viability of irradiated cells at all doses used was greater than 90%. Results: mean þ S.D. of four experiments in duplicate.
*P6 0.05 vs. control. C: Cytosol fraction from control or radiated (400 cGy) cells was isolated (7^8 h) and dialyzed at 4‡C to minimize feed-
back inhibition by GSH. GSH synthetic rate was determined as indicated in Section 2 in the presence of glutamate, glycine and cysteine. D:
Activity of GSH synthetase was determined using Q-glutamylcysteine and glycine as GSH precursors and the GSH-bimane £uorescent adduct
followed over time. Results are the mean þ S.D. of four di¡erent experiments. *P6 0.05 vs. control.
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ditions by turning on protective systems to maintain cellular
functions under these circumstances, we determined the regu-
lation of GSH in HepG2 cells in response to radiation. We
followed the GSH levels in HepG2 cells after exposure to a
moderate dose of radiation (400 cGy) (Fig. 1). Within 30 min
following radiation, there was a depletion of total GSH equiv-
alents in cells, re£ected mainly in the form of reduced GSH
(17.8 þ 2.7 nmol/106 cells), that was accompanied by an in-
crease in the form of GSSG (2.8 þ 1.1 nmol/106 cells) com-
pared to control cells (22.1 þ 3.1 and 1.4 þ 0.8 nmol/106 cells
for GSH and GSSG, respectively). Such a decrease was tran-
sitory as GSH levels recovered to control values by 2 h. In-
terestingly, however, reduced GSH levels increased above con-
trol values (23.4 þ 2.7 vs. 31.4 þ 3.2 nmol/106 cells, for control
and irradiated cells, respectively) by 3 h following radiation
with minimal e¡ect on GSSG (1.8 þ 0.9 vs. 2.1 þ 1.1 nmol/106
cells), e¡ect that persisted for the next 9^12 h (Fig. 1A). Ex-
posure of cells to lower doses of radiation (100^200 cGy) did
not result in signi¢cant increase of total GSH levels (Fig. 1B).
A similar e¡ect was observed when cells were exposed to a
greater radiation dose (1000 cGy), as cellular reduced GSH
levels increased over control values (35^40%) after 5 h post-
radiation. The initial depletion of reduced GSH and subse-
quent decrease in GSH/GSSG, re£ecting a radiation-induced
oxidative stress, occurred to a greater extent at 1000 cGy than
at 400 cGy (4.3 vs. 6.4, GSH to GSSG ratio, respectively),
e¡ect that preceded the increment of cellular reduced GSH
evoked by radiation. A further indication of the oxidative
stress elicited by radiation was the increase in ROS (20^
30%), monitored as the £uorescence of cells labeled with
DCFDA, a £uorescent probe sensitive to ROS [22]. Despite
the evidence of radiation-induced oxidative stress, especially
at the dose of 1000 cGy, cells remained intact and viable
(s 90%), judged by the lack of trypan blue or propidium
iodide staining and release of cytosolic enzymes to the extra-
cellular media. These ¢ndings indicate that the e¡ects of radi-
ation on GSH homeostasis were not due to the selection of a
subpopulation of HepG2 cells that were resistant to radiation.
To assess if the up-regulation of cellular GSH induced by
radiation was due to a greater capacity to synthesize GSH, we
determined the synthetic rate of GSH in cell-free extracts iso-
lated from control or HepG2 cells after being exposed to
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Fig. 2. Regulation of Q-GCS-HS mRNA by ionizing radiation. Total RNA from HepG2 cells was extracted at di¡erent times post-radiation
and hybridized with cDNA for Q-GCS-HS and analyzed by Northern blot as described in Section 2. Identity of cDNA for Q-GCS-HS was veri-
¢ed by sequencing. 18S band was used as internal control. The variability in the 18S band intensity does not re£ect loss of viability of irradi-
ated cells. The magnitude of increase of Q-GCS-HS mRNA was calculated relative to the levels of 18S to minimize the variability in RNA load-
ing between lanes. Percentage increase over control for three di¡erent experiments is shown. *P6 0.05 vs. control.
Fig. 3. E¡ect of radiation on Q-GCS-HS-CAT promoter constructs. Generation of Q-GCS-HS-CAT constructs was accomplished as described in
Section 2. After 8 h post-radiation (400 cGy), cell extracts were obtained and used for CAT activity by ELISA normalized for protein content.
The pCAT reporter vector did not result in measurable CAT activity in cell extracts. Results are mean þ S.D. of n=4 individual experiments.
*P6 0.05 vs. control.
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radiation. Cellular extracts were dialyzed to minimize feed-
back inhibition of GSH on Q-GCS and then incubated with
unlimited GSH precursors and cofactors. The dynamic syn-
thetic rate of GSH was determined using monochlorobimane
as a probe which forms a highly £uorescent adduct with GSH
by a reaction catalyzed by GST transferases [21]. GSH syn-
thesis in cytosol extracts incubated with GSH cofactors (glu-
tamate, glycine and ATP) and cysteine as the sulfur amino
acid, re£ects the activities of both Q-GCS and GSH synthe-
tase. The GSH synthetic rate increased signi¢cantly (40^50%)
in cell extracts isolated from HepG2 cells that have been ir-
radiated at 400 cGy compared to control cells (Fig. 1C). Q-
Glutamylcysteine, the product of Q-GCS, is the substrate for
GSH synthetase to which glycine is added forming the ¢nal
product, GSH. When Q-glutamylcysteine was used in the in
vitro synthetic assay instead of cysteine, the formation of
GSH re£ected the activity of GSH synthetase. In contrast to
the results obtained using cysteine as sulfur donor, no change
in GSH formation from Q-glutamylcysteine was observed, in-
dicating that radiation did not a¡ect the activity of GSH
synthetase (Fig. 1D). Therefore, our ¢ndings show for the ¢rst
time that ionizing radiation confers a greater capacity to syn-
thesize GSH due to an induction in the activity of Q-GCS.
Due to the critical role of GSH in determining the survival
of cells under stress, our ¢ndings suggest that the induction of
Q-GCS stands as a vital strategy to control the unwanted
consequences of ROS. These revealing ¢ndings constitute an-
other example of the induction of protecting enzymes, includ-
ing Q-CGS, in response to multiple stimuli, such as carcino-
gens, alkylating drugs, chemotherapeutic agents and cytokines
such as IL-6 and TNF [12^17,26^28]. The mechanism where-
by unrelated compounds such as chemotherapeutic, alkylating
quinones, cytokines and electrophiles lead to an increase in Q-
GCS activity is not completely known and may be mediated
by the involvement of speci¢c cis-regulatory elements located
in the promoter of Q-GCS.
GSH exerts a feedback inhibition on Q-GCS, the regulatory
and rate limiting enzyme in GSH biosynthesis [23]. Since a fall
in GSH levels preceded its subsequent induction, it is conceiv-
able that a lower feedback inhibition of GSH on Q-GCS may
contribute to its induction. Q-GCS is comprised of two sub-
units, heavy and light chain that are discoordinately synthe-
sized. The catalytic activity resides in the heavy subunit (Q-
GCS-HS) whereas the light chain lowers the Km for glutamate
and increases the feedback inhibition by GSH on the heavy
subunit [23]. To assess if the increased Q-GCS activity was
paralleled by an up-regulation of Q-GCS-HS mRNA, we de-
termined Q-GCS-HS mRNA levels in HepG2 following radi-
ation. As shown (Fig. 2), Northern blot analysis revealed an
increase in the Q-GCS-HS mRNA (2^3-fold) in cells exposed
to radiation compared to control, detectable 3 h following
radiation.
To determine if the increased Q-GCS-HS mRNA levels in-
duced by radiation re£ected a stabilization of their mRNA or
were due to a greater transcriptional rate of this gene, we
performed functional analyses of a partial Q-GCS-HS pro-
moter fragment subcloned in a CAT reporter vector. As
seen in Fig. 3, cells that were transfected with the full length
construct 31088/+255, displayed a signi¢cant stimulation of
CAT activity following radiation. Furthermore, the 5P £ank-
ing region of Q-GCS-HS promoter has been recently charac-
terized, identifying several regulatory cis acting elements
[11,12,17], including UB and AP-1 binding sites. NF-UB has
been shown to exert a protective role against stress and radi-
ation, perhaps by inducing detoxifying enzymes, such as DT-
diaphorase [29,30]. Since radiation leads to activation of NF-
UB [31^33] and in view of previous studies that have shown
that the transcription of Q-GCS is associated with activation
of AP-1 [11,13,34], deletion constructs containing separately
AP-1 and NF-UB regions were generated to determine the role
of these factors in the transcription of Q-GCS-HS by radia-
tion. Following transient transfection of these constructs into
FEBS 20148 1-5-98
Fig. 4. Activation of AP-1 by radiation. A: Nuclear extracts from irradiated (400 cGy; full bars) and control cells (open bars) were isolated at
various times after radiation and incubated in the presence of labeled AP-1 oligonucleotide as described in Section 2. Only retarded band of
DNA-AP-1 complex is shown. B: Densitometric quantitation of AP-1 activation. Results are the mean þ S.D. of n=3 individual preparations.
*P6 0.05 vs. control.
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HepG2 cells, CAT activity was determined in cell extracts
isolated from radiated cells. Compared to stimulation of
CAT activity in cell extracts isolated from irradiated HepG2
that were transfected with the full length construct, the shorter
construct (277 bp) containing NF-UB-like and XRE/ARE-like
responsive elements, resulted in minimal CAT expression by
radiation. High levels of transcription activation of Q-GCS-HS
promoter were induced by radiation when cells were trans-
fected with the deletion plasmid 3756/+216 containing AP-
1/MRE cis-regulatory elements, as the magnitude of CAT
activity induced by radiation was similar to that seen with
the full length plasmid (Fig. 3).
To establish whether radiation induced DNA binding to the
AP-1 binding site in the Q-GCS promoter, we performed elec-
trophoretic mobility shift assays with nuclear extracts pre-
pared from irradiated HepG2 cells using a radiolabeled oligo-
nucleotide encompassing the AP-1. As seen in Fig. 4, there
was a time dependent increase in AP-1 activation which was
maximal after 4 h post-radiation. The speci¢city of binding
for AP-1 was established from competition of labeled AP-1
oligonucleotide with a molar excess of unlabeled AP-1 (not
shown). Altogether, these results indicate that NF-UB is not
required in the regulation of Q-GCS-HS by radiation, whereas
involvement of other putative enhancer elements including
AP-1 are required for such an e¡ect. At present we cannot
completely discard the involvement of other cis-regulatory
elements located further upstream in the 5P £anking region
of Q-GCS-HS gene, which have been recently described [17].
Our ¢nding indicating a role for AP-1 in the transcription of
Q-GCS is in agreement with previous reports [11,13,34]. The
mechanism underlying the activation of AP-1 by radiation has
not been fully characterized. In this regard, it has been shown
that radiation results in the release of ceramide, a lipid signal-
ling intermediate, from the plasma membrane of irradiated
cells, by hydrolysis of sphingomyelin. It is conceivable that
ceramide may play a role in the activation of AP-1 by radia-
tion, as has been shown previously for other agonists which
use ceramide as a signal transducer, through activation of
stress-activated protein kinases [35^38]. In addition, since
ceramide causes oxidative stress by generating ROS [39,40],
these reactive species may also play a role in the activation of
AP-1.
Despite our ¢ndings showing that the up-regulation of the
catalytic subunit of Q-GCS is su⁄cient to raise the levels of
cellular GSH, the e¡ect of radiation on the regulatory subunit
of Q-GCS (the light subunit) remains to be determined.
Although previous studies have indicated a minimal change
in the regulatory subunit of Q-GCS [16,17], recent ¢ndings
have shown a coordinate induction of both heavy and light
subunits of Q-GCS in response to redox cycling quinones [41].
Finally, it can be envisioned that cells challenged by oxida-
tive stress induced by radiation may up-regulate the GSH
levels to cope with the potentially deleterious e¡ects of free
radicals. Indeed, our ¢ndings indicate that exposure of HepG2
cells to moderate doses of radiation up-regulates the Q-GCS-
HS mRNA levels and activity leading to greater content of the
radioprotective antioxidant, GSH. Although the magnitude of
the increased levels of GSH in irradiated cells may appear
modest, the capacity to replenish cell GSH rather than the
absolute levels of GSH would constitute an e⁄cient tool to
confer protection against the overproduction of ROS and the
subsequent oxidative stress generated by radiation.
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